Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.34 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23636556 | 0.91 | MEN1 (0.37) | MAPK14KDM4EMAPTCYP1A2GAA | |
| SCHEMBL23636598 | 0.86 | MAPK14 (0.34) | MAPK14MAPTGAANR1I2L3MBTL1 | |
| SCHEMBL23636591 | 0.82 | CYP3A4 (0.34) | MAPK14CYP3A4CYP2C9CYP2C19VCAM1 | |
| SCHEMBL23636572 | 0.81 | VCAM1 (0.33) | VCAM1TDP1 | |
| SCHEMBL23636569 | 0.80 | PDE3B (0.34) | SMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL23636585 | 0.80 | MTNR1A (0.40) | MAPTGAAL3MBTL1TSHRMAPK1 | |
| SCHEMBL23636583 | 0.80 | PTGS2 (0.35) | — | |
| SCHEMBL31026341 | 0.79 | TSHR (0.37) | KDM4EMAPTL3MBTL1TSHRMAPK1 | |
| SCHEMBL21586951 | 0.79 | PDE2A (0.35) | MAPTGAAL3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL23636568 | 0.79 | PTGS2 (0.33) | VCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214321-A1 | NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214321-A1 | NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | SULT1A1, XDH, SULT2A1 | MAPK14 4252/4885KDM4E 1879/4885MAPT 2230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.